CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

OKYO Pharma advances toward Phase 3 FDA trial - ICYMI

Phase 3Positive
AI Analysis

Summary

OKYO Pharma is advancing toward Phase 3 FDA trial initiation. The company has progressed its development program to the Phase 3 stage.

Clinical Trial Data

Phase

Phase 3

Importance:6/10
Sentiment:
0.50
Phase 3FDAclinical trialregulatory progress
Related Companies

Read the original article

Published by yahoo_finance on July 11, 2026 2:00 PM

Read Original